GENE News and Press, Genetic Technologies Ltd From 08/30/23

MELBOURNE, Australia, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline driven genomics-based tests in health, wellness and serious disease is pleased to report annual results for the...

MELBOURNE, Australia, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, ASX: GTG, “Company”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to provide an update on the company’s activities via the lates...

2023-08-09 00:11:04 ET Genetic Technologies Limited (GENE) Q4 2023 Earnings Conference Call August 08, 2023 07:15 PM ET Company Participants Adrian Mulcahy - Investor Relations Simon Morriss - Chief Executive Officer Tony Di Pietro - Chief Financial Officer C...

2023-08-08 13:40:23 ET Genetic Technologies press release ( NASDAQ: GENE ): Q4'23 receipts were A$2.1M. Receipts from customers was A$8.8M for the 12 months to 30 June, up 29% Y/Y. For further details see: Genetic Technologies reports Q4 results

2023-08-07 11:20:35 ET Major earnings expected before the bell on Tuesday include: Duke Energy ( DUK ) Barrick Gold ( GOLD ) Medical Properties Trust ( MPW ) Organon ( OGN ) United Parcel Service ( UPS ) For further details see: Notable ea...

2023-07-28 13:26:38 ET Genetic Technologies ( NASDAQ: GENE ) said Friday its June-quarter receipts were A$2.1 million. At the end of June 2023, the company had A$7.9 million in cash and cash equivalents. Cash receipts from customers for the financial ye...

MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, “Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, is pleased to provide this Quarterly Business Upda...

2023-07-21 09:07:39 ET Genetic Technologies ( NASDAQ: GENE ) has received notification from Nasdaq as it is not in compliance with the minimum bid price requirement. The closing bid price for the company’s ADS was below US$1.00 for 34 consecutive trading days. ...

MELBOURNE, Australia, July 21, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”) a global leader in genomics-based tests in health, wellness and serious disease, advises that it has received notification (the “Notification”) from The Nasda...

MELBOURNE, Australia, May 23, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and serious disease is pleased to announce that the Company’s geneType Brea...